Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
<p>Abstract</p> <p>Background</p> <p>Oncogene amplification and overexpression occur in tumor cells. Amplification status may provide diagnostic and prognostic information and may lead to new treatment strategies. Chromosomal regions 8p12, 8q24, 11q13, 17q12 and 20q13 a...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-10-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/6/245 |
| _version_ | 1831569468040413184 |
|---|---|
| author | Viens Patrice Zemmour Christophe Finetti Pascal Geneix Jeannine Esterni Benjamin Gelsi-Boyer Véronique Monville Florence Cervera Nathalie Ginestier Christophe Sircoulomb Fabrice Letessier Anne Charafe-Jauffret Emmanuelle Jacquemier Jocelyne Birnbaum Daniel Chaffanet Max |
| author_facet | Viens Patrice Zemmour Christophe Finetti Pascal Geneix Jeannine Esterni Benjamin Gelsi-Boyer Véronique Monville Florence Cervera Nathalie Ginestier Christophe Sircoulomb Fabrice Letessier Anne Charafe-Jauffret Emmanuelle Jacquemier Jocelyne Birnbaum Daniel Chaffanet Max |
| author_sort | Viens Patrice |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Oncogene amplification and overexpression occur in tumor cells. Amplification status may provide diagnostic and prognostic information and may lead to new treatment strategies. Chromosomal regions 8p12, 8q24, 11q13, 17q12 and 20q13 are recurrently amplified in breast cancers.</p> <p>Methods</p> <p>To assess the frequencies and clinical impact of amplifications, we analyzed 547 invasive breast tumors organized in a tissue microarray (TMA) by fluorescence in situ hybridization (FISH) and calculated correlations with histoclinical features and prognosis. BAC probes were designed for: (i) two 8p12 subregions centered on <it>RAB11FIP1 </it>and <it>FGFR1 </it>loci, respectively; (ii) 11q13 region centered on <it>CCND1</it>; (iii) 12p13 region spanning <it>NOL1</it>; and (iv) three 20q13 subregions centered on <it>MYBL2, ZNF217 </it>and <it>AURKA</it>, respectively. Regions 8q24 and 17q12 were analyzed with <it>MYC </it>and <it>ERBB2 </it>commercial probes, respectively.</p> <p>Results</p> <p>We observed amplification of 8p12 (amplified at <it>RAB11FIP1 </it>and/or <it>FGFR1</it>) in 22.8%, 8q24 in 6.1%, 11q13 in 19.6%, 12p13 in 4.1%, 17q12 in 9.9%, 20q13<sup>Z </sup>(amplified at <it>ZNF217 </it>only) in 9.9%, and 20q13<sup>Co </sup>(co-amplification of two or three 20q13 loci) in 8.5% of cases. The 8q24, 12p13, and 17q12 amplifications were correlated with high grade. The most frequent single amplifications were 8p12 (9.8%), 8q24 (3.3%) and 12p13 (3.3%), 20q13<sup>Z </sup>and 20q13<sup>Co </sup>(1.6%) regions. The 17q12 and 11q13 regions were never found amplified alone. The most frequent co-amplification was 8p12/11q13. Amplifications of 8p12 and 17q12 were associated with poor outcome. Amplification of 12p13 was associated with basal molecular subtype.</p> <p>Conclusion</p> <p>Our results establish the frequencies, prognostic impacts and subtype associations of various amplifications and co-amplifications in breast cancers.</p> |
| first_indexed | 2024-12-17T12:34:39Z |
| format | Article |
| id | doaj.art-b9460cb0ab6b43c9ab2a59e96dfeebd5 |
| institution | Directory Open Access Journal |
| issn | 1471-2407 |
| language | English |
| last_indexed | 2024-12-17T12:34:39Z |
| publishDate | 2006-10-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj.art-b9460cb0ab6b43c9ab2a59e96dfeebd52022-12-21T21:48:23ZengBMCBMC Cancer1471-24072006-10-016124510.1186/1471-2407-6-245Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancersViens PatriceZemmour ChristopheFinetti PascalGeneix JeannineEsterni BenjaminGelsi-Boyer VéroniqueMonville FlorenceCervera NathalieGinestier ChristopheSircoulomb FabriceLetessier AnneCharafe-Jauffret EmmanuelleJacquemier JocelyneBirnbaum DanielChaffanet Max<p>Abstract</p> <p>Background</p> <p>Oncogene amplification and overexpression occur in tumor cells. Amplification status may provide diagnostic and prognostic information and may lead to new treatment strategies. Chromosomal regions 8p12, 8q24, 11q13, 17q12 and 20q13 are recurrently amplified in breast cancers.</p> <p>Methods</p> <p>To assess the frequencies and clinical impact of amplifications, we analyzed 547 invasive breast tumors organized in a tissue microarray (TMA) by fluorescence in situ hybridization (FISH) and calculated correlations with histoclinical features and prognosis. BAC probes were designed for: (i) two 8p12 subregions centered on <it>RAB11FIP1 </it>and <it>FGFR1 </it>loci, respectively; (ii) 11q13 region centered on <it>CCND1</it>; (iii) 12p13 region spanning <it>NOL1</it>; and (iv) three 20q13 subregions centered on <it>MYBL2, ZNF217 </it>and <it>AURKA</it>, respectively. Regions 8q24 and 17q12 were analyzed with <it>MYC </it>and <it>ERBB2 </it>commercial probes, respectively.</p> <p>Results</p> <p>We observed amplification of 8p12 (amplified at <it>RAB11FIP1 </it>and/or <it>FGFR1</it>) in 22.8%, 8q24 in 6.1%, 11q13 in 19.6%, 12p13 in 4.1%, 17q12 in 9.9%, 20q13<sup>Z </sup>(amplified at <it>ZNF217 </it>only) in 9.9%, and 20q13<sup>Co </sup>(co-amplification of two or three 20q13 loci) in 8.5% of cases. The 8q24, 12p13, and 17q12 amplifications were correlated with high grade. The most frequent single amplifications were 8p12 (9.8%), 8q24 (3.3%) and 12p13 (3.3%), 20q13<sup>Z </sup>and 20q13<sup>Co </sup>(1.6%) regions. The 17q12 and 11q13 regions were never found amplified alone. The most frequent co-amplification was 8p12/11q13. Amplifications of 8p12 and 17q12 were associated with poor outcome. Amplification of 12p13 was associated with basal molecular subtype.</p> <p>Conclusion</p> <p>Our results establish the frequencies, prognostic impacts and subtype associations of various amplifications and co-amplifications in breast cancers.</p>http://www.biomedcentral.com/1471-2407/6/245 |
| spellingShingle | Viens Patrice Zemmour Christophe Finetti Pascal Geneix Jeannine Esterni Benjamin Gelsi-Boyer Véronique Monville Florence Cervera Nathalie Ginestier Christophe Sircoulomb Fabrice Letessier Anne Charafe-Jauffret Emmanuelle Jacquemier Jocelyne Birnbaum Daniel Chaffanet Max Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers BMC Cancer |
| title | Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers |
| title_full | Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers |
| title_fullStr | Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers |
| title_full_unstemmed | Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers |
| title_short | Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers |
| title_sort | frequency prognostic impact and subtype association of 8p12 8q24 11q13 12p13 17q12 and 20q13 amplifications in breast cancers |
| url | http://www.biomedcentral.com/1471-2407/6/245 |
| work_keys_str_mv | AT vienspatrice frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT zemmourchristophe frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT finettipascal frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT geneixjeannine frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT esternibenjamin frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT gelsiboyerveronique frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT monvilleflorence frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT cerveranathalie frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT ginestierchristophe frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT sircoulombfabrice frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT letessieranne frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT charafejauffretemmanuelle frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT jacquemierjocelyne frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT birnbaumdaniel frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers AT chaffanetmax frequencyprognosticimpactandsubtypeassociationof8p128q2411q1312p1317q12and20q13amplificationsinbreastcancers |